MedTrace Logo

Statin Compliance of Patients With Non-insulin-dependent Diabetes

NCT04007133 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2019-07-17

No results posted yet for this study

Summary

The diabetic population has an increased cardiovascular risk compared to the general population.

Hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors, or "statins", are considered as the standard treatment for hypercholesterolemia.

Many patients with non-insulin-dependent diabetes are prescribed with statins, both for primary prevention, before the first cardiovascular event, and as secondary prevention, to avoid recurrence.

However, compliance to these drugs may be difficult due to polypharmacy, side effects (myalgia) or tiredness.

The purpose of this study is to determine the compliance of diabetic patients with statins searching for important factors which could favor adherence.

Conditions

  • Non-insulin-dependent Diabetes

Interventions

OTHER

Girerd test

This is a simple and quick questionnaire, composed of 6 questions with a binary yes/no answer. It allows to assess the degree of compliance with the prescribed treatment to better identify the constraints related to the treatment.

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Lille Catholic University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2018-07-12
Completion
2018-07-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04007133 on ClinicalTrials.gov